Richard Slayman, 62, underwent the four-hour procedure on March 16 to treat end-stage kidney disease. The pig kidney, provided by Cambridge, Mass.-based eGenesis, contained 69 genomic edits to improve its compatibility with humans.
“This moment — leaving the hospital today with one of the cleanest bills of health I’ve had in a long time — is one I wished would come for many years,” Mr. Slayman said in an April 3 news release shared with Becker’s. “I want to thank anyone who has seen my story and sent well-wishes, especially patients waiting for a kidney transplant. Today marks a new beginning not just for me, but for them, as well.”
The procedure represents a historical milestone in the field of xenotransplantation and could offer a potential solution to the global organ shortage, according to Massachusetts General.
Surgeons at University of Maryland Medical Center in Baltimore previously transplanted genetically-modified pig hearts into two patients, though both died within a few weeks of their procedures.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
